Effectiveness and safety of erlotinib in 2 patients with carcinoma of the cervix
Efectividad y seguridad de erlotinib en 2 pacientes con carcinoma de cérvix uterino
Leído
2500
Vecesse ha leído el artículo
948
Total PDF
1552
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 18 | 11 | 29 |
| 2025 5 | 64 | 21 | 85 |
| 2025 4 | 55 | 21 | 76 |
| 2025 3 | 54 | 16 | 70 |
| 2025 2 | 48 | 17 | 65 |
| 2025 1 | 45 | 39 | 84 |
| 2024 12 | 41 | 17 | 58 |
| 2024 11 | 37 | 22 | 59 |
| 2024 10 | 34 | 15 | 49 |
| 2024 9 | 43 | 15 | 58 |
| 2024 8 | 47 | 23 | 70 |
| 2024 7 | 29 | 18 | 47 |
| 2024 6 | 29 | 25 | 54 |
| 2024 5 | 31 | 16 | 47 |
| 2024 4 | 27 | 21 | 48 |
| 2024 3 | 28 | 7 | 35 |
| 2024 2 | 30 | 24 | 54 |
| 2024 1 | 31 | 11 | 42 |
| 2023 12 | 32 | 3 | 35 |
| 2023 11 | 58 | 25 | 83 |
| 2023 10 | 14 | 7 | 21 |
| 2023 9 | 27 | 22 | 49 |
| 2023 8 | 17 | 8 | 25 |
| 2023 7 | 18 | 5 | 23 |
| 2023 6 | 22 | 11 | 33 |
| 2023 5 | 19 | 19 | 38 |
| 2023 4 | 18 | 11 | 29 |
| 2023 3 | 17 | 14 | 31 |
| 2023 2 | 15 | 17 | 32 |
| 2022 1 | 21 | 13 | 34 |
| 2022 12 | 72 | 11 | 83 |
| 2022 11 | 24 | 11 | 35 |
| 2022 10 | 18 | 9 | 27 |
| 2022 9 | 19 | 27 | 46 |
| 2022 8 | 24 | 10 | 34 |
| 2022 7 | 30 | 8 | 38 |
| 2022 6 | 39 | 19 | 58 |
| 2022 5 | 12 | 13 | 25 |
| 2022 4 | 24 | 6 | 30 |
| 2022 3 | 18 | 5 | 23 |
| 2022 2 | 12 | 6 | 18 |
| 2021 1 | 18 | 7 | 25 |
| 2021 12 | 13 | 8 | 21 |
| 2021 11 | 14 | 11 | 25 |
| 2021 10 | 6 | 7 | 13 |
| 2021 9 | 4 | 9 | 13 |
| 2021 8 | 2 | 3 | 5 |
| 2021 7 | 6 | 9 | 15 |
| 2021 6 | 4 | 6 | 10 |
| 2021 5 | 5 | 4 | 9 |
| 2021 4 | 1 | 12 | 13 |
| 2021 3 | 6 | 8 | 14 |
| 2021 2 | 7 | 6 | 13 |
| 2020 1 | 4 | 8 | 12 |
| 2020 12 | 7 | 6 | 13 |
| 2020 11 | 4 | 4 | 8 |
| 2020 10 | 2 | 4 | 6 |
| 2020 9 | 7 | 7 | 14 |
| 2020 8 | 5 | 6 | 11 |
| 2020 7 | 4 | 4 | 8 |
| 2020 6 | 5 | 1 | 6 |
| 2020 5 | 2 | 4 | 6 |
| 2020 4 | 4 | 3 | 7 |
| 2020 3 | 5 | 3 | 8 |
| 2020 2 | 2 | 3 | 5 |
| 2020 1 | 1 | 7 | 8 |
| 2019 12 | 6 | 6 | 12 |
| 2019 11 | 1 | 3 | 4 |
| 2019 10 | 2 | 2 | 4 |
| 2019 9 | 2 | 5 | 7 |
| 2019 8 | 3 | 6 | 9 |
| 2019 7 | 3 | 9 | 12 |
| 2019 6 | 1 | 10 | 11 |
| 2019 5 | 13 | 32 | 45 |
| 2019 4 | 7 | 17 | 24 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 2 | 2 | 4 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 8 | 7 | 15 |
| 2018 11 | 6 | 0 | 6 |
| 2018 10 | 3 | 9 | 12 |
| 2018 9 | 1 | 0 | 1 |
| 2018 8 | 3 | 0 | 3 |
| 2018 7 | 0 | 2 | 2 |
| 2018 6 | 1 | 2 | 3 |
| 2018 5 | 0 | 1 | 1 |
| 2018 2 | 3 | 0 | 3 |
| 2017 12 | 3 | 1 | 4 |
| 2017 10 | 4 | 1 | 5 |
| 2017 9 | 1 | 2 | 3 |
| 2017 8 | 1 | 1 | 2 |
| 2017 7 | 4 | 1 | 5 |
| 2017 6 | 6 | 1 | 7 |
| 2017 5 | 7 | 1 | 8 |
| 2017 4 | 14 | 1 | 15 |
| 2017 3 | 5 | 47 | 52 |
| 2017 2 | 1 | 1 | 2 |
| 2016 1 | 1 | 1 | 2 |
| 2016 12 | 5 | 0 | 5 |
| 2016 11 | 7 | 2 | 9 |
| 2016 10 | 8 | 4 | 12 |
| 2016 9 | 6 | 0 | 6 |
| 2016 8 | 10 | 1 | 11 |
| 2016 7 | 3 | 0 | 3 |
Mostrar todo
